The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

MURPHY ANDREW J

Reporting owner CIK 0001796226 · Co-Chief Scientific Officer

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.MURPHY ANDREW JMURPHY ANDREW JMURPHY ANDREW J · October 13, 2026 · Exercise / conversion · Common StockMURPHY ANDREW J · December 5, 2025 · Stock award · Non-Qualified Stock Option (right to buy)MURPHY ANDREW J · December 5, 2025 · Stock award · Common StockMURPHY ANDREW J · October 29, 2025 · Exercise / conversion · Common StockOct 29, 2025Oct 13, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 13, 2026REGENERON PHARMACEUTICALS, INC.Common StockMURPHY ANDREW JExercise / conversion
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)MURPHY ANDREW JStock award
Dec 5, 2025REGENERON PHARMACEUTICALS, INC.Common StockMURPHY ANDREW JStock award
Oct 29, 2025REGENERON PHARMACEUTICALS, INC.Common StockMURPHY ANDREW JExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: REGENERON PHARMACEUTICALS, INC.REGN · company listings
MURPHY ANDREW JCo-Chief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M17,000381.92Value: 6,492,640Currency not specifiedView ↗
Trade: REGENERON PHARMACEUTICALS, INC.REGN · company listings
MURPHY ANDREW JEVP Research
Stock awardNon-Qualified Stock Option (right to buy)Derivative security · Code A18,3150Value: 0Currency not specifiedView ↗
Trade: REGENERON PHARMACEUTICALS, INC.REGN · company listings
MURPHY ANDREW JEVP Research
Stock awardCommon StockNon-derivative security · Code A3,7150Value: 0Currency not specifiedView ↗
Trade: REGENERON PHARMACEUTICALS, INC.REGN · company listings
MURPHY ANDREW JEVP Research
Exercise / conversionCommon StockNon-derivative security · Code M35,000555.67Value: 19,448,450Currency not specifiedView ↗